Non Serious Adverse Drug Reactions Report

Start Date:2016-05-27 End Date:2016-05-30
Study :EMR700623-541Investigator :Ying ZhongCountry of Investigator :ChinaSiteNo:C05
Subject No :C05-0001Subject Initials :XFZDOB :01/21/1988Sex:FemaleRace:AsianHeight:159cmWeight:50kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/01/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS08/16/201508/18/2015RelatedSevere
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableNoneResolved
Event Description:Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml,ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
oophorocystectomyUK-Jul-2013Not on treatment/medication
salpingoplastyUK-Feb-2014Not on treatment/medication
salpingitis after previous tubal occlusionUK-Feb-2014Not on treatment/medicationOngoing



27-MAY-16
Ying Zhong/EMR700623-541/C05-0001
Page 1 of27
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-05-27 End Date:2016-05-30
Study :EMR700623-541Investigator :Ying ZhongCountry of Investigator :ChinaSiteNo:C05
Subject No :C05-0021Subject Initials :FYZDOB :08/28/1990Sex:FemaleRace:AsianHeight:150cmWeight:45kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment08/04/2015225
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS08/19/201508/21/2015RelatedMild
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
Protocol procedure**,Concomitant medication**(Othervalue:)Not applicableNoneResolved
Event Description:abdominal distention;Drug:Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection 500ml,ivgtt bid calcium gluconate injection 10ml+dextrose injection 500ml ivgtt qd 19-Aug-2015 / 21-Aug-2015
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
salpingocatheterismUK-Unk-2012Not on treatment/medication



29-MAY-16
Ying Zhong/EMR700623-541/C05-0021
Page 2 of27